Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia. - Wikidata - awgldk - TriplyDB

Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.

Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.

http://www.wikidata.org/entity/Q37644988

about

miRnalyze: an interactive database linking tool to unlock intuitive microRNA regulation of cell signaling pathways.A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc.miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO-Im.MiR-181 family-specific behavior in different cancers: a meta-analysis view.

P2860

Q33787523-55E1F74E-3ED9-448B-A7C7-E4450D5B2E6F Q33889001-F19C1BBF-3825-4BA5-B2CB-552364AA3902 Q38546133-0D9C7216-7701-4804-9D94-7C9C140CD3B3 Q41082813-F797EBFA-45BA-4016-9A76-E533BF7C2B72 Q44637964-7587E5CE-6F41-4CE5-A5F2-C8341BFD7E9A Q47733035-E0FB7ED1-D75B-4868-88E9-620F1EF7121D Q48218461-B2556EC8-2CD7-4931-8413-7BD3EFEE1914 Q50073977-883CF7BC-3E15-4EA0-A6D7-4789C1473012

P2860

Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.

http://www.wikidata.org/entity/Q37644988

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@en

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@nl

type

label

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@en

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@nl

prefLabel

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@en

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@nl

P1433

Q37644988-9E6CEED3-A886-42AC-8324-E93D155EC038

P1476

Q37644988-01BB196C-FB9A-42ED-9479-0DC2D8C84D94

P2093

Q37644988-040DDE02-7065-421E-B3C6-E88F834DF5E8

Q37644988-1609BC66-387A-4F03-8223-D7C7142CF154

Q37644988-2188BEDA-815C-4A60-BB73-C5BB18C79897

Q37644988-50AE1C38-F687-4AB5-BA8C-3FDCE7469D11

Q37644988-6C2F6C03-2C9F-4917-A81D-8E35C768D8AD

Q37644988-B9F42CF8-72C8-4EB2-B4E6-DC6D2955867F

Q37644988-C9C29797-C964-43FA-9E6E-4E613DB97609

P2860

Q37644988-0DA30325-5F30-4732-90BD-AC19C0B48F4F

Q37644988-0FA6A470-9890-49C3-AD0B-637CE3632B36

Q37644988-145E4147-DA85-410A-8E63-94873615BD47

Q37644988-1E92D944-DEE4-4C6A-AED5-F8F09E895F4E

Q37644988-29ACF6B2-B6AF-4F45-B22D-7CEAF32A5782

Q37644988-2E40C300-B240-4DF9-9D4C-D5D1D51A0834

Q37644988-330E6710-4634-4D3E-9CC5-144A6888E98B

Q37644988-3751256A-6974-4834-BCD4-7B859B6D1BCF

Q37644988-3EEA02BA-07E3-4616-B3A5-6DDC6A509C8D

Q37644988-43B7CB4F-E812-4420-BAE1-49FD41C4CC07

P304

Q37644988-D1407887-B389-431F-8A8D-F46CF6C67EDD

P31

Q37644988-D3FCD5E6-1CB8-47BE-AE21-92892EB92212

P356

Q37644988-8556F4D5-9004-4491-B289-7DBAD50955C0

P407

Q37644988-CA08325E-2CC9-4C3C-B653-6473FA8C0F63

P433

Q37644988-BC074BB6-A8F4-4FBA-BF28-6670AC67E2F5

P478

Q37644988-8F53377A-C3AD-4462-8F83-BCB02570535C

P577

Q37644988-15051CC0-986F-4C2C-A1CD-266FA35FE76B

P698

Q37644988-EE33F34E-6C63-4949-A82F-1B7A09F9C544

P921

Q37644988-4433F4AF-18FA-4C68-A28D-277816E2B257

P932

Q37644988-12A53B5D-874D-42B4-90A2-9825B7AE552A

P356

ONCOTARGET.11054

P1433

P1476

Upregulation of miR-181c inhib ...... n chronic myelocytic leukemia.

@en

P2093

Huimin Zhou

http://www.w3.org/2001/XMLSchema#string

Li Jia

http://www.w3.org/2001/XMLSchema#string

Lifen Zhao

http://www.w3.org/2001/XMLSchema#string

Nana Li

http://www.w3.org/2001/XMLSchema#string

Xiaobo Song

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

Yuan Miao

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of human ST8SiaIII sialyltransferase provides insight into cell-surface polysialylation

The PI3K pathway as drug target in human cancer

Identification of novel genes coding for small expressed RNAs

ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor

Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.

MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.

Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors.

Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells

P304

60074-60086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11054

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27527856

http://www.w3.org/2001/XMLSchema#string

P921

P932

5312369

http://www.w3.org/2001/XMLSchema#string